-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Theralink Technologies, Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from Q3 2010 to Q4 2023.
- Theralink Technologies, Inc. Earnings Per Share, Diluted for the quarter ending December 31, 2023 was 0 USD/shares.
- Theralink Technologies, Inc. annual Earnings Per Share, Diluted for 2023 was -0.01 USD/shares.
- Theralink Technologies, Inc. annual Earnings Per Share, Diluted for 2022 was 0 USD/shares.
- Theralink Technologies, Inc. annual Earnings Per Share, Diluted for 2019 was -19 USD/shares, a 309% decline from 2018.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)